Online inquiry

IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7730MR)

This product GTTS-WK7730MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the Additional GABA Compounds protein. This product can be used in Osteoblast-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001164737.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 799
UniProt ID P30988
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7730MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK12200MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADAMTS16
GTTS-WK12600MR IVTScrip™ mRNA-Human Aggrecan, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Aggrecan
GTTS-WK26823MR IVTScrip™ mRNA-Human ARID2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARID2
GTTS-WK25997MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ASB16-AS1
GTTS-WK22020MR IVTScrip™ mRNA-Human ARHGEF4, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF4
GTTS-WK20068MR IVTScrip™ mRNA-Human AOAH, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AOAH
GTTS-WK21721MR IVTScrip™ mRNA-Human ARHGEF6, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF6
GTTS-WK15221MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD36BP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW